Search from website
Search from website
Figure 1. Coomassie-stained SDS-PAGE analysis of monoclonal antibody to SARS-CoV-2 Spike RBD, clone 27C2. 4-12% gradient gel is used for analysis. Lane 1. Monoclonal antibody to SARS-CoV-2 Spike RBD, clone 27C2 (-DTT). Lane 2. Size Marker. Lane 3. Monoclonal antibody to SARS-CoV-2 Spike RBD, clone 27C2 (+DTT). Lane 4. Size Marker.
Figure 2. HPLC analytical SEC for final product.
Figure 3. HPLC analytical SEC after 3 freeze-thaw cycles.
Figure 4. Octet RED96e analysis, antibody was loaded on sensor for capture of Spike S1 protein.(for reference only; data shown are from a single production batch at release and may not be representative of other batches)
Catalogue #
R1-158-100
Name
Human IgG1-lambda antibody to SARS CoV-2 S1 RBD (clone 27C2)
Target
SARS-CoV-2 virus
Target Description
SARS-CoV-2 virus (PBMCs isolated from patients recovered from SARS-CoV-2 infection, antibodies discovered by using HybriFree Technology)
Alternative Names
Spike glycoprotein, S glycoprotein
Uniprot ID
P0DTC2
Clonality
Human monoclonal
Clone
27C2
Class
hIgG1
Reactivity
SARS-CoV-2 Spike S1 RBD, also recognized SARS CoV-2 Trimeric Spike in Octet analysis.
Application
ELISA
Protocol
Concentration
1 mg/ml
Buffer
PBS pH 7.4
Shipping
Shipped on dry ice.
Storage
Store in -65...-85 °C. Avoid multiple freeze-thaw cycles.
This product is for research use only
TECHNICAL ASSISTANCE
Please refer any technical questions to
technical.support@icosagen.com
© 2026 Icosagen
